Expanding U.S. Mold-Building Facility
In response to growing customer demand in our global medical device and drug delivery business, GW Plastics has expanded and upgraded our state-of-the-art tooling facility in Royalton, Vermont and purchased additive manufacturing technology. We have invested over $2M in our Royalton mold-building facility in the last 12 months to support our R&D and expansion efforts. With recent expansions of our tooling facilities in the U.S. and China and the acquisition of Avenue Mould Solutions in Ireland, we now have both the expertise and infrastructure to give our customers peace of mind that we can support their complex programs on three continents.
Advanced Metal 3D Printing
GW Plastics has invested in metal 3D printing technology for conformal cooling to improve cycle times – in some cases up to 30% – as well as component quality and design flexibility. This additive manufacturing technology streamlines tool design, reducing the components needed to build a mold and the overall investment our customers need to make. We are proud to offer this level of technology to our customers to ensure their products are being manufactured in the best mold possible. GW is one of only a handful of precision mold builders that have invested in this technology.
Global Tooling Growth
This announcement comes months after GW’s purchase of Avenue Mould Solutions, an Ireland-based premier precision mold-building, machining, and injection molding company. This acquisition gives GW Plastics a unique industry position with precision mold-building facilities in North America, Asia, and Europe, in addition to injection molding and contract manufacturing. GW Plastics now ranks as one of the plastic industry’s largest manufacturers of precision molds. More importantly that just having the advanced tooling capability, GW Plastics now has the global capacity to handle large-scale programs, including ultra-high-cavitation, multi-component, and silicone mold-building for our multi-national customers.